The Pandemic Experience in Southeast Asia: Interface Between SARS-CoV-2, Malaria, and Dengue

Area of Science:

• Epidemiology
• Virology
• Public Health

Background:

• Southeast Asia initially controlled SARS-CoV-2 but faced a surge by July 2021.
• The surge was driven by Alpha (B.1.1.7) and Delta (B.1.617.2) variants.
• Factors contributing to the surge include underestimating prior prevalence and overestimating cross-protective immunity.

Purpose of the Study:

• To analyze the factors contributing to the SARS-CoV-2 surge in Southeast Asia.
• To examine the impact of vaccine rollout and endemic diseases on the pandemic response.

Main Methods:

• Analysis of epidemiological data on SARS-CoV-2 case numbers and variant prevalence.
• Review of government responses, cultural factors, and vaccine rollout efficacy.
• Assessment of the impact of co-existing malaria and dengue on disease management.

Main Results:

• The region experienced a significant increase in cases driven by highly transmissible variants.
• Variable vaccine rollout speeds and efficacy influenced disease burden.
• Serological cross-reactivity with endemic viruses complicates diagnostic accuracy.

Conclusions:

• The SARS-CoV-2 pandemic in Southeast Asia is complex, influenced by viral variants, immunity, and co-endemic diseases.
• Effective containment requires addressing diagnostic challenges and resource competition between endemic and pandemic diseases.